Janssen HLA - Search Results

1

Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a.

Rijckborst V, Hansen BE, Ferenci P, Brunetto MR, Tabak F, Cakaloglu Y, Lanza AG, Messina V, Iannacone C, Massetto B, Regep L, Colombo M, Janssen HLA, Lampertico P. Rijckborst V, et al. Among authors: janssen hla. J Hepatol. 2012 May;56(5):1006-1011. doi: 10.1016/j.jhep.2011.12.007. Epub 2012 Jan 13. J Hepatol. 2012. PMID: 22245886

2

Suicide associated with alfa-interferon therapy for chronic viral hepatitis.

Janssen HL, Brouwer JT, van der Mast RC, Schalm SW. Janssen HL, et al. J Hepatol. 1994 Aug;21(2):241-3. doi: 10.1016/s0168-8278(05)80402-7. J Hepatol. 1994. PMID: 7989716

3

Measurement of HBsAg to monitor hepatitis B viral replication in patients on alpha-interferon therapy.

Janssen HL, Kerhof-Los CJ, Heijtink RA, Schalm SW. Janssen HL, et al. Antiviral Res. 1994 Apr;23(3-4):251-7. doi: 10.1016/0166-3542(94)90022-1. Antiviral Res. 1994. PMID: 8042863

4

Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.

Janssen HL, Berk L, Heijtink RA, ten Kate FJ, Schalm SW. Janssen HL, et al. Hepatology. 1993 Mar;17(3):383-8. Hepatology. 1993. PMID: 8444411 Clinical Trial.

5

Repeated courses of alpha-interferon for treatment of chronic hepatitis type B.

Janssen HL, Schalm SW, Berk L, de Man RA, Heijtink RA. Janssen HL, et al. J Hepatol. 1993;17 Suppl 3:S47-51. doi: 10.1016/s0168-8278(05)80423-4. J Hepatol. 1993. PMID: 8509639

6

Interferon alfa for chronic hepatitis B infection: increased efficacy of prolonged treatment. The European Concerted Action on Viral Hepatitis (EUROHEP).

Janssen HL, Gerken G, Carreño V, Marcellin P, Naoumov NV, Craxi A, Ring-Larsen H, Kitis G, van Hattum J, de Vries RA, Michielsen PP, ten Kate FJ, Hop WC, Heijtink RA, Honkoop P, Schalm SW. Janssen HL, et al. Hepatology. 1999 Jul;30(1):238-43. doi: 10.1002/hep.510300113. Hepatology. 1999. PMID: 10385662 Clinical Trial.

7

Interferon-alpha therapy in chronic hepatitis B: early monitoring of hepatitis B e antigen may help to decide whether to stop or to prolong therapy.

Heijtink RA, Janssen HL, Hop WC, Osterhaus AD, Schalm SW. Heijtink RA, et al. J Viral Hepat. 2000 Sep;7(5):382-6. doi: 10.1046/j.1365-2893.2000.00246.x. J Viral Hepat. 2000. PMID: 10971827 Clinical Trial.

8

The prognostic value of histology in the assessment of patients with Budd-Chiari syndrome.

Tang TJ, Batts KP, de Groen PC, van Hoek B, Haagsma EB, Hop WC, Janssen HL. Tang TJ, et al. J Hepatol. 2001 Sep;35(3):338-43. doi: 10.1016/s0168-8278(01)00131-3. J Hepatol. 2001. PMID: 11592594

9

Combination and newer therapies for chronic hepatitis B.

Schalm SW, De Man RA, Janssen HL. Schalm SW, et al. J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S338-41. doi: 10.1046/j.1440-1746.17.s3.24.x. J Gastroenterol Hepatol. 2002. PMID: 12472960

10

In vivo immunization following virus suppression: a novel approach for inducing immune control in chronic hepatitis B.

Sprengers D, Janssen HL, Kwekkeboom J, Niesters HG, de Man RA, Schalm SW. Sprengers D, et al. J Viral Hepat. 2003 Jan;10(1):7-9. doi: 10.1046/j.1365-2893.2003.00395.x. J Viral Hepat. 2003. PMID: 12558905

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

602 results

Search Page

Filters